通过疫苗时代，犹他州儿童中肺炎球菌病的流行病学演变。
Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.
机构信息
Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA.
出版信息
Pediatr Infect Dis J. 2011 Dec;30(12):1100-3. doi: 10.1097/INF.0b013e318232ee3e.
Abstract
From 1996 to 2009, we analyzed changes in pneumococcal disease (PD) in Utah children aged <18 years using International Classification of Diseases, ninth revision coded hospital discharges. We observed a sustained decrease in the incidence of PD among children <5 years in 2001-2004 (-36%) and 2005-2009 (-34%) compared with 1996-2000 (pre-7-valent pneumococcal conjugate vaccine). Decreases were primarily in bacteremia, uncomplicated pneumonia, and meningitis. In contrast, significant increases in complicated pneumonia/empyema were noted in children <5 years (+95% and +85%) and 5 to 17 years (+2% and +70%). Despite decreases in PD among Utah children, complicated pneumonia/empyema has increased during the 7-valent pneumococcal conjugate vaccine era.
摘要
从 1996 年到 2009 年，我们使用国际疾病分类第九版编码的住院记录分析了犹他州<18 岁儿童中肺炎球菌病 (PD) 的变化。我们观察到，与 1996-2000 年（7 价肺炎球菌结合疫苗之前）相比，2001-2004 年（-36%）和 2005-2009 年（-34%）<5 岁儿童 PD 的发病率持续下降。下降主要发生在菌血症、单纯性肺炎和脑膜炎。相比之下，<5 岁儿童（+95%和+85%）和 5 至 17 岁儿童（+2%和+70%）中复杂性肺炎/脓胸的发生率显著增加。尽管犹他州儿童的 PD 有所减少，但在 7 价肺炎球菌结合疫苗时代，复杂性肺炎/脓胸的发病率有所增加。
相似文献
1
Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.
Pediatr Infect Dis J. 2011 Dec;30(12):1100-3. doi: 10.1097/INF.0b013e318232ee3e.
2
The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.
Pediatr Infect Dis J. 2012 Mar;31(3):228-34. doi: 10.1097/INF.0b013e31823dcc72.
3
Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
Pediatr Infect Dis J. 2006 Mar;25(3):250-4. doi: 10.1097/01.inf.0000202137.37642.ab.
4
Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
Vaccine. 2016 Jan 20;34(4):474-478. doi: 10.1016/j.vaccine.2015.12.010. Epub 2015 Dec 17.
5
Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.
Pediatr Infect Dis J. 2005 Apr;24(4):320-3. doi: 10.1097/01.inf.0000157090.40719.9b.
6
Invasive Streptococcus pneumoniae infections in children in Kamikawa and Soya subprefecture, Hokkaido, Japan, 2000-2010, before the introduction of the 7-valent pneumococcal conjugate vaccine.
J Infect Chemother. 2011 Dec;17(6):799-802. doi: 10.1007/s10156-011-0264-8. Epub 2011 Jun 25.
7
Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
Vaccine. 2018 Jan 8;36(3):421-426. doi: 10.1016/j.vaccine.2017.11.054. Epub 2017 Dec 7.
8
Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands.
Vaccine. 2016 Feb 17;34(8):1077-85. doi: 10.1016/j.vaccine.2015.12.066. Epub 2016 Jan 8.
9
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.
Vaccine. 2015 Nov 27;33(48):6666-74. doi: 10.1016/j.vaccine.2015.10.089. Epub 2015 Oct 29.
10
Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era.
Vaccine. 2011 Nov 15;29(49):9123-6. doi: 10.1016/j.vaccine.2011.10.009. Epub 2011 Oct 14.
引用本文的文献
1
Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.
Vaccine. 2016 Dec 7;34(50):6243-6249. doi: 10.1016/j.vaccine.2016.10.062. Epub 2016 Nov 7.
2
Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics.
Clin Infect Dis. 2016 Sep 1;63(5):619-626. doi: 10.1093/cid/ciw357. Epub 2016 Jun 9.
3
Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah.
Pediatrics. 2013 Sep;132(3):421-8. doi: 10.1542/peds.2013-0621. Epub 2013 Aug 26.
4
Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.
Pediatrics. 2013 Jul;132(1):e17-24. doi: 10.1542/peds.2012-3900. Epub 2013 Jun 3.
5
What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?
Infect Dis Clin North Am. 2013 Mar;27(1):157-75. doi: 10.1016/j.idc.2012.11.007. Epub 2012 Dec 12.
6
The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.
Pediatr Infect Dis J. 2012 Mar;31(3):228-34. doi: 10.1097/INF.0b013e31823dcc72.
本文引用的文献
1
Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.
MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):258-61.
2
Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States.
Clin Infect Dis. 2010 Mar 15;50(6):805-13. doi: 10.1086/650573.
3
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
J Infect Dis. 2010 Jan 1;201(1):32-41. doi: 10.1086/648593.
4
Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
Pediatr Infect Dis J. 2010 Apr;29(4):289-93. doi: 10.1097/INF.0b013e3181c15471.
5
Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):144-8.
6
Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996-2002.
Ann Epidemiol. 2008 Feb;18(2):139-46. doi: 10.1016/j.annepidem.2007.09.006.
7
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
J Infect Dis. 2007 Nov 1;196(9):1346-54. doi: 10.1086/521626. Epub 2007 Oct 4.
8
Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.
JAMA. 2007 Apr 25;297(16):1784-92. doi: 10.1001/jama.297.16.1784.
9
Epidemiology of invasive pneumococcal disease in Kumasi, Ghana.
Trans R Soc Trop Med Hyg. 2007 Apr;101(4):405-13. doi: 10.1016/j.trstmh.2006.08.014. Epub 2006 Nov 28.
10
Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types.
Infect Immun. 2006 Jun;74(6):3360-5. doi: 10.1128/IAI.01442-05.
Zotero 插件